Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Receivables - Other: 2012-2025

Historic Receivables - Other for Gyre Therapeutics (GYRE) over the last 2 years, with Sep 2025 value amounting to $230,000.

  • Gyre Therapeutics' Receivables - Other fell 82.31% to $230,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $230,000, marking a year-over-year decrease of 82.31%. This contributed to the annual value of $5.0 million for FY2024, which is N/A change from last year.
  • Per Gyre Therapeutics' latest filing, its Receivables - Other stood at $230,000 for Q3 2025, which was down 0.00% from $230,000 recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Receivables - Other peaked at $5.0 million during Q4 2024, and registered a low of $230,000 during Q1 2025.
  • Its 3-year average for Receivables - Other is $1.2 million, with a median of $1.2 million in 2023.
  • Its Receivables - Other has fluctuated over the past 5 years, first spiked by 333.33% in 2024, then tumbled by 82.31% in 2025.
  • Gyre Therapeutics' Receivables - Other (Quarterly) stood at $1.2 million in 2023, then increased by 8.33% to $5.0 million in 2024, then slumped by 82.31% to $230,000 in 2025.
  • Its last three reported values are $230,000 in Q3 2025, $230,000 for Q2 2025, and $230,000 during Q1 2025.